As of 2025-03-21, the Relative Valuation of Appili Therapeutics Inc (APLI.TO) is (0.70) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Appili Therapeutics Inc based on Relative Valuation is -2104.0%.
The range of the Relative Valuation is (0.69) - (0.72) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 23.2x | 22.2x |
| Forward P/E multiples | 19.5x - 22.1x | 20.8x |
| Fair Price | (0.69) - (0.72) | (0.70) |
| Upside | -2076.0% - -2158.0% | -2104.0% |
| Date | P/E |
| 2025-03-04 | -0.92 |
| 2025-02-28 | -1.07 |
| 2025-02-27 | -1.07 |
| 2025-02-26 | -1.07 |
| 2025-02-25 | -1.07 |
| 2025-02-24 | -1.23 |
| 2025-02-21 | -0.92 |
| 2025-02-20 | -1.23 |
| 2025-02-19 | -1.07 |
| 2025-02-18 | -0.92 |
| 2025-02-14 | -0.92 |
| 2025-02-13 | -0.92 |
| 2025-02-11 | -1.07 |
| 2025-02-07 | -1.07 |
| 2025-02-05 | -0.92 |
| 2025-02-04 | -1.07 |
| 2025-02-03 | -1.07 |
| 2025-01-31 | -1.07 |
| 2025-01-30 | -0.92 |
| 2025-01-29 | -1.07 |
| 2025-01-27 | -1.07 |
| 2025-01-24 | -0.92 |
| 2025-01-23 | -1.07 |
| 2025-01-22 | -1.07 |
| 2025-01-21 | -1.07 |
| 2025-01-20 | -1.07 |
| 2025-01-17 | -1.07 |
| 2025-01-16 | -1.23 |
| 2025-01-15 | -1.23 |
| 2025-01-14 | -1.23 |
| 2025-01-13 | -1.07 |
| 2025-01-10 | -1.07 |
| 2025-01-09 | -0.92 |
| 2025-01-08 | -0.92 |
| 2025-01-03 | -1.07 |
| 2024-12-30 | -1.07 |
| 2024-12-27 | -1.07 |
| 2024-12-24 | -1.07 |
| 2024-12-23 | -1.07 |
| 2024-12-19 | -1.07 |
| 2024-12-18 | -1.07 |
| 2024-12-17 | -1.23 |
| 2024-12-13 | -1.23 |
| 2024-12-12 | -1.23 |
| 2024-12-11 | -1.07 |
| 2024-12-10 | -1.07 |
| 2024-12-09 | -1.23 |